CC‐486 DLBCL‐001 study design and dosing schedule. ECOG PS, Eastern Cooperative Oncology Group performance status; FL, follicular lymphoma; IPI, International Prognostic Index; NHL, non-Hodgkin lymphoma; RP2D, recommended phase 2 dose. See Figure 1 in the article by Martin et al that begins on page 1147.